Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2019 / Article

Research Article | Open Access

Volume 2019 |Article ID 3595761 | 9 pages | https://doi.org/10.1155/2019/3595761

Nephroprotective Role of Beta vulgaris L. Root Extract against Chlorpyrifos-Induced Renal Injury in Rats

Academic Editor: Filippo Fratini
Received07 May 2019
Revised16 Aug 2019
Accepted20 Sep 2019
Published22 Nov 2019


Organophosphorus pesticides (OPs) are widely used for agricultural and housekeeping purposes. Exposure to OPs is associated with the progression of several health issues. Antioxidant agents may be powerful candidates to minimise adverse reactions caused by OPs. The aim of the present study was to evaluate the nephroprotective effects of red beetroot extract (RBR) against chlorpyrifos- (CPF-) induced renal impairments. CPF induced kidney dysfunction, as demonstrated by changes in serum creatinine and urea levels. Moreover, CPF exposure induced oxidative stress in the kidneys as determined by increased malondialdehyde and nitric oxide levels, decreased glutathione content, decreased catalase, superoxide dismutase, glutathione peroxidase, and glutathione reductase activities, and decreased nuclear factor (erythroid-derived 2)-like-2 factor expression. In addition, CPF induced inflammation in renal tissue as evidenced by increased release of tumor necrosis factor-alpha and interleukin-1β and upregulation of inducible nitric oxide synthase. Furthermore, CPF promoted cell death as demonstrated by decreased Bcl-2 and increased Bax and caspase-3 levels. Treatment with RBR one hour prior to CPF treatment blocked the effects observed in response to CPF alone. Our results suggest that RBR could be used to alleviate CPF-induced nephrotoxicity through antioxidant, anti-inflammatory, and antiapoptotic activities.

1. Introduction

Contamination with pesticides has emerged as a serious problem worldwide. Chlorpyrifos (O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate, CPF) is a moderately persistent broad-spectrum organophosphorus pesticide extensively used in cultivation due to its effectiveness in insect and worm control. CPF principally acts as an acetylcholinesterase (AChE) inhibitor [1]. AChE is found mainly at neuromuscular junctions and terminates neurotransmission of ACh. However, CPF was shown to target the immune and antioxidant defence systems [2]. Due to the widespread use of CPF, humans may be exposed to CPF directly or indirectly. The main routes of exposure to CPF are through consumption of contaminated foods, inhalation, and adsorption through the skin during preparation and application. Exposure to CPF induces several pathological conditions including neurotoxicity, endocrine disturbance, reproductive toxicity, immunological perturbations, and hepatorenal injury in both animals and humans. Exposure to CPF reportedly elicits toxicity via several mechanisms including generation of reactive oxygen species (ROS), production of proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β), and induction of apoptosis [3].

B. vulgaris (also known as beetroot) is a plant member of the Amaranthaceae family (formerly placed in the Chenopodiaceae family). It is extensively cultivated worldwide, particularly in subtropical and tropical countries in Africa and in Asia, and in Mediterranean countries [4]. The roots contain a number of minerals including K, Cu, Mg, Zn, Ca, P, and Na, vitamins, and phytochemicals such as polyphenols and carotenoids. Unlike other red plants that contain anthocyanin pigments, the red/purple colour of beetroot is due to the presence of betalain pigments such as betacyanins and betaxanthins [5]. Beetroot has been used in folk medicine due to its vasodilatory, antihypertensive, antidiabetic, hepatoprotective, antioxidant, anti-inflammatory, and anticarcinogenic properties [6]. Furthermore, beetroot has also been shown to increase athletic performance [7].

The aim of this study was to evaluate the potential benefits of red beetroot methanolic extract (RBR) against CPF-induced nephrotoxicity by evaluating oxidative status, inflammation, apoptosis, and renal histological alterations in male rats.

2. Materials and Methods

CPF was purchased from a pesticide and chemical company located in Riyadh, KSA. Prior to administration, CPF was diluted with distilled water (dH2O) to a final concentration of 10 mg CPF/3.5 ml·H2O (w/v). Fresh red beetroot was obtained from a local market in Riyadh, KSA in November 2018. The plant material was identified and authenticated by a botanist (Botany Department, College of Science, King Saud University, Riyadh, KSA). The roots were washed with running tap water and ground into small pieces using an electrical blender. The methanolic extract of RBR was prepared by macerating the obtained juice and particles three times in aqueous methanol (70%) for 48 h at a ratio of 1 : 10 (w/v) at 4°C. The extract was filtered, and the organic solvent was removed by vacuum evaporation followed by lyophilisation. The obtained RBR was stored at −80°C until further analysis.

2.1. Experimental Design

Twenty-eight adult male Wistar albino rats (11 weeks old; 140–170 g) were housed five per cage in the animal facility of the Zoology Department, College of Science, King Saud University (KSA) under controlled conditions of 22–24°C and 40–60% relative humidity with a normal light/dark cycle. All experiments were performed in accordance with the Guidelines of the National Program for Science and Technology of the Faculty of Science, King Saud University. The study protocols were approved by the Ethics Committee of King Saud University (Riyadh, KSA; H-01-R-059).

After one week of acclimation, the rats were divided randomly into four groups (n = 7) and gavaged with the indicated treatments once daily for 28 consecutive days. The treatment groups were as follows: control group: received physiological saline solution (0.9% NaCl); RBR group: administered RBR at a dose of 300 mg/kg; CPF group: received CPF solution at a dose of 10 mg/kg; and RBR + CPF group: received 300 mg/kg RBR 1 h prior to administration of 10 mg/kg CPF. CPF dosing was performed according to the method outlined by Peiris and Dhanushka [8]. The oral dose of RBR was selected based on a preliminary experiment using three doses of RBR: 100, 200, and 300 mg/kg. This preliminary study showed that oral administration of RBR at a dose of 300 mg/kg effectively minimised CPF-induced nephrotoxicity (data not shown). Twenty-four hours after the final treatment, the rats were sacrificed under anaesthesia. The kidneys were excised immediately and cut into small pieces. One piece was weighed and homogenised for biochemical assays. A second piece was kept at −80°C for mRNA extraction and evaluation of gene expression. The third piece was placed in neutral-buffered formalin for histological examination.

2.2. Kidney Weight Estimate

The relative kidney weight was estimated according to the following formula:

2.3. Biochemical Parameters
2.3.1. Serum Kidney Function Parameters

The serum levels of urea and creatinine were determined using kits supplied by Randox Laboratories (Crumlin, United Kingdom) according to the manufacturer’s instructions.

2.3.2. Preparation of Tissue Homogenates

Kidney tissues were homogenised in 50 mM tris-HCl (pH 7.4) to a final concentration of 10% (w/v). The obtained homogenates were centrifuged at 5,000 ×g for 10 min at 4°C. The supernatants were divided into aliquots and stored at −80°C until further use for biochemical analyses. The renal protein content was determined according to the method of Lowry et al. [9]. Bovine serum albumin (BSA) was used as a standard.

2.3.3. Determination of Oxidative Stress Markers

The levels of malondialdehyde (MDA), an end product of lipid peroxidation (LPO), were determined using the thiobarbituric acid reactive substances method according to Ohkawa et al. [10]. Nitric oxide (NO) was estimated according to method described by Green et al. [11]. Superoxide dismutase (SOD) activity was measured according to the method described by Sun et al. [12]. Catalase (CAT) activity was measured according to the method described by Aebi [13]. Glutathione peroxidase (GPx) activity was measured according to the method described by Paglia and Valentine [14]. Glutathione reductase activity was measured according to the method described by Factor et al. [15]. Glutathione (GSH) quantitation was performed according to the method described by Ellman [16].

2.3.4. Quantitation of Proinflammation Cytokine Levels

The renal levels of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were determined using ELISA kits purchased from Thermo Fisher Scientific (catalogue number: ERIL1B) and R&D Systems (catalogue number: RTA00), respectively. Analyses were performed according to the manufacturer’s instructions.

2.3.5. Determination of the Levels and Activity of Apoptotic Markers

The levels of the pro- and antiapoptotic proteins, Bcl-2 and Bax, were determined using ELISA kits purchased from Cusabio (catalogue numbers: CSB-EL006328RA and CSB-E08854r) and BioVision, Inc. (catalogue number: E4513) according to the suppliers’ protocols, respectively. The activity of caspase-3 was determined using a calorimetric kit obtained from Sigma-Aldrich (catalogue number CASP3C).

2.3.6. Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR) Analysis

Total RNA from kidney tissue was extracted using the standard TRIzol® protocol (Invitrogen, Carlsbad, CA, USA). The obtained RNA was immediately converted to complementary DNA. The primer sequences used to determine the levels of nuclear factor (erythroid-derived 2)-like-2 factor (Nfe2l2) inducible nitric oxide synthase (Nos2), IL-1β, TNF, Bax, Casp3, and Bcl2 gene expressions and are provided in Table 1 according to Abdel Moneim [17]. Power SYBR® Green Master Mix was utilised for RT-qPCR analysis. Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) was used as the housekeeping gene, and its expression remained unaltered throughout the experiment. The fold changes in the examined genes were determined using the 2−ΔΔCt method [18]. All experiments were performed in triplicate.

NameAccession numberForward primer (5′---3′)Reverse primer (5′---3′)


The abbreviations of the genes: Gapdh, glyceraldehyde-3-phosphate dehydrogenase; Nfe2l2, nuclear factor (erythroid-derived 2)-like-2 factor; Nos2, inducible nitric oxide synthase; IL-1β, interleukin-1 beta; TNF, tumor necrosis factor; Bcl2: B-cell lymphoma 2; Bax, Bcl-2-like protein 4; Casp3, caspase-3.
2.3.7. Histopathological Examination

The kidney tissue was fixed in 10% neutral-buffered formalin for 24 h at room temperature, dehydrated, paraffinised, sectioned (5 μm), and stained with hematoxylin and eosin for light microscopy examination. Images were captured using a Nikon microscope (Eclipse E200-LED, Tokyo, Japan) at a magnification of ×400.

2.4. Statistical Analysis

The results are expressed as means ± standard errors of the mean (n = 7). Comparisons between two groups were made using Student’s t-test, and comparisons between three or more groups were made by one-way analysis of variance and post hoc Duncan’s test using SPSS version 20.0.; values <0.05 indicated statistical significance.

3. Results

3.1. Effect of RBR on Kidney Function Markers following CPF Exposure

After 4 weeks of 10 mg/kg CPF exposure, blood creatinine and urea levels, which are markers of kidney function, were significantly increased (Figure 1), indicating that CPF caused nephrotoxicity in male rats. CPF treatment also resulted in increased kidney index. Pretreatment with RBR 1 h prior to CPF administration reduced the increases in creatinine, urea, and kidney index values compared to those in rats only treated with CPF, suggesting that RBR protected against renal damage.

3.2. Effect of RBR on Redox Status in Kidney Tissue following CPF Exposure

Because oxidative stress was a likely mechanism of CPF-induced nephrotoxicity, the oxidative stress markers including MDA, NO, antioxidant enzymes, and GSH were evaluated. Kidneys of rats treated with CPF had significantly increased () MDA and NO levels, significantly decreased GSH content, and significantly decreased SOD, CAT, GPx, and GR activities compared to those in the control group. RBR pretreatment blocked CPF-induced changes in redox status, suggesting that RBR induced antioxidant effects in CPF-treated rat kidneys (Figures 2 and 3).

Nrf2 is an important regulator of cellular resistance to xenobiotics. Nrf2 regulates the basal and enhanced expression of a variety of antioxidant response element-dependent genes to mitigate the physiological and pathophysiological effects of xenobiotic exposure. To investigate whether RBR induced antioxidant effects through Nrf2, Nfe2l2 mRNA expression in kidney tissue was measured using qRT-PCR. Nfe2l2 mRNA expression in kidney tissue was significantly downregulated in the CPF-treated rats compared to that in the control rats (Figure 4). RBR pretreatment resulted in significant upregulation of Nfe2l2 mRNA expression in CPF-treated rats, demonstrating that RBR prevented nephrotoxicity in rats by enhancing Nfe2l2 expression.

3.3. Effect of RBR on the Inflammatory Response in Kidney Tissue following CPF Treatment

Transcriptional levels of the proinflammatory cytokines Tnfα, IL-1β, and Nos2 were determined in kidney tissue of rats treated with CPF. As demonstrated by RT-qPCR, the mRNA expression of TNF-α, IL-1β, and Nos2 was significantly upregulated in kidney tissue of rats treated with CPF compared to that in the control group (Figure 5). Furthermore, ELISA was used to confirm that the transcription-level results correlated to changes in translation. Our results showed that CPF treatment resulted in significant elevation in TNF-α and IL-1β protein levels compared to those in the control group. However, RBR pretreatment reduced CPF-induced up-regulation of TNF-α, IL-1β, and Nos2 and prevented CPF-induced increases in TNF-α and IL-1β protein levels, suggesting that RBR exerted anti-inflammatory effects that could contribute to protection against CPF-induced nephrotoxicity.

3.4. Effect of RBR on Apoptosis-Related Proteins in Renal Tissue following CPF Exposure

To determine if apoptosis played a role in CPF-induced nephrotoxicity in rats, we measured Bcl-2, Bax, and caspase-3 mRNA and protein levels in kidney tissue. The proapoptotic markers Bax and caspase-3, and the antiapoptotic marker Bcl-2 were measured by qRT-PCR and ELISA. Our results showed that subchronic exposure to CPF significantly increased the mRNA and protein expression of Bax and caspase-3, and decreased the mRNA and protein expression levels of Bcl-2 compared to those in the control group. Pretreatment with RBR protected the renal tissue against CPF-induced nephrotoxicity by preventing CPF-induced changes in Bax, Bcl-2, and caspase-3 (Figure 6). Our results suggested that RBR increased antiapoptotic protein expression, thus exerting a protective effect against CPF-induced nephrotoxicity.

3.5. Effect of RBR on CPF-Induced Histopathological Alterations in Kidney Tissue

Representative histopathological sections of the kidney tissue from control and the treatment groups are shown in Figure 7. The kidney tissue of the control rats and rats treated with RBR alone had normal kidney structure with normal renal tubules and glomeruli. CPF exposure for 28 days resulted in swelling of epithelial cells, oedema of the intertubular spaces, focal haemorrhage, inflammatory cell infiltration, vacuolisation, and development of intraluminal casts. Pretreatment with RBR minimised the pathological alterations induced by CPF exposure in kidney tissue.

4. Discussion

The kidney plays an important role in metabolism and excretion of chemicals and drugs, as it contains most common xenobiotic detoxifying enzymes [19]. Xenobiotic-induced renal injury is dependent on the chemical nature of the xenobiotic, the dose, and the duration of exposure. Using antioxidant agents to protect renal tissue against organophosphorus compound exposure has been previously reported [20]. The aim of the current study was to assess the potential nephroprotective role of RBR against CPF-induced renal injury. Exposure to CPF significantly increased the levels of serum creatinine and urea. Several physiological alterations have been observed following CPF exposure [21, 22]. Creatinine and urea are essential markers of kidney function in patients suffering from renal injury. Creatinine and urea are metabolic waste products mainly excreted from the body in the urine. Hence, increased levels of these markers following CPF exposure reflect renal dysfunction [23]. Increased creatinine in the serum reflects decreased glomerular filtration rate, while elevated urea indicates dysfunctional reabsorption [23]. Previous studies observed glomerular and renal tubular impairments in response to CPF exposure [24].

Interestingly, pretreatment with RBR significantly mitigated CPF-induced increases in serum creatinine and urea levels, demonstrating that RBR exerted renoprotective effects through maintaining membrane integrity and limiting the leaking of these biomarkers into the blood. Our findings agreed with those in a previous report El Gamal et al. [25] which showed that oral administration of the beetroot extract protected renal tissue against gentamicin-induced nephrotoxicity in rats, as determined by mitigation of serum creatinine and urea elevations.

Our study showed that CPF induced redox imbalance, as evidenced by increased MDA and NO levels, decreased GSH levels, and decreased activity of SOD, CAT, GPx, and GR in renal tissue. Oxidative stress has been suggested to be the primary mechanism of CPF-induced nephrotoxicity [21, 22]. MDA is formed by ROS-induced lipid peroxidation and is commonly used as a biomarker of oxidative stress. Increased MDA levels indicated damage to kidney tissue and altered membrane function [22, 26]. NO is a biological mediator involved in several physiological functions. Increased NO in response to CPF exposure suggests induction of nitrosative stress responses, likely due to upregulation of Nos2, the rate-limiting enzyme in NO synthesis [23]. GSH is a cellular tripeptide that acts as a potent scavenger of intracellular free radicals [27]. The marked decrease in renal GSH levels in response to CPF exposure was due to its consumption by scavenging of free radicals [23]. Depletion of the GSH pool also occurs through conjugation of GSH with electrophilic metabolites of CPF and inhibition of accumulation of MDA [28]. The enzymatic antioxidant enzymes SOD, CAT, GPx, and GR play fundamental roles in the elimination of reactive oxygen and nitrogen species which are responsible for cellular oxidative damage [29]. SOD metabolises superoxide radicals produced as a byproduct of increased metabolic activity in response to xenobiotics [30]. Deceased SOD activity indicates impairment of the renal antioxidant defence system against superoxide radicals [22]. CAT metabolises hydrogen peroxide, which is produced mainly in the mitochondria. Decreased CAT activity enhances accumulation of hydrogen peroxide, resulting in renal damage [22]. GPx is a selenium-containing antioxidant enzyme, which prevents decomposition of lipid hydroperoxides through reduction of hydroperoxides to alcohols. GPx also decreases free H2O2, thus providing cellular protection against oxidative stress [22]. GPx activity is dependent upon cellular GSH availability [22]. Therefore, we hypothesised that the observed decrease in GPx activity in response to CPF was due to decreased GSH in the renal tissue. Inactivation of these endogenous antioxidants in renal tissue following CPF treatment has been attributed to accumulation of cytotoxic free radicals in the kidney [20, 22]. In addition to disruption of the cellular antioxidant defence system, CPF significantly downregulated Nfe2l2 mRNA expression in renal tissue. Nrf2 provides cellular protection against oxidative insults through increased expression of enzymes and proteins critical to the antioxidant response. Disturbances in Nrf2 signalling have been reported in several pathological conditions [31].

RBR treatment significantly mitigated the effects of CPF administration on Nfe2l2 mRNA expression, GSH levels, and SOD, CAT, GPx, and GR activity, suggesting that RBR prevented CPF-induced damage through antioxidant mechanisms in the kidney. The antioxidant properties of RBR have been discussed in previous reports [3234]. The antioxidant properties of RBR have been previously attributed to its rich betalain content, which triggers activation of Nrf2, resulting in enhancement of the expression of endogenous antioxidant enzymes [35]. In addition, RBR is a nitrate donor, resulting in the ability to scavenge reactive oxygen and nitrogen species including superoxide and hydrogen peroxide [36]. Indeed, RBR maintained antioxidant effectors at normal cellular levels despite oxidative challenge through upregulation of Nfe2l2 mRNA expression.

Our results showed excessive release of TNF-α and IL-1β in response to CPF exposure, indicating that CPF induced inflammation in renal tissue. We also showed that CPF increased mRNA expression of TNF-α and IL-1β which was likely responsible for the increased levels of TNF-α and IL-1β. A previous study suggested that CPF induced oxidative stress, leading to inflammation, which includes increased production of TNF-α and IL-1β [23]. El-Sayed et al. [28] attributed the elevation in TNF-α and IL-1β to the overproduction of ROS and activation of nuclear factor kappa B (NF-κB). Based on this attribution, we hypothesised that ROS scavengers/quenchers might effectively minimise CPF-induced inflammation in renal tissue. RBR exerted anti-inflammatory activity when administered prior to CPF as evidenced by decreased levels of TNF-α and IL-1β. El Gamal et al. [25] showed that RBR administration decreased inflammatory cell infiltration and significantly decreased the release of proinflammatory cytokines through the deactivation of NF-κB in renal tissue following treatment with gentamicin. Moreover, betalains, the major active constituents in beetroot, were found to exert anti-inflammatory effects through inhibition of the expression of cyclooxygenase-2 in vitro [37].

Programmed cell death is considered a critical mechanism of CPF-induced toxicity. In the current study, CPF enhanced the apoptotic pathway in renal tissue as demonstrated by downregulation of Bcl-2 and upregulation of Bax and caspase-3. Bcl-2 is an essential regulator of apoptosis, and its overexpression is associated with suppression of ROS-induced apoptosis. In contrast, Bax and caspase-3 overexpression enhances cellular impairment and promotes proapoptotic signalling. A previous report showed that CPF exposure induced downregulation of Bcl-2 and upregulation of Bax and caspase-3, suggesting that CPF may trigger cell death via caspase-dependent mitochondrial pathways [38]. Initiation of apoptotic cascades in response to CPF has been also attributed to mitochondrial dysfunction and overproduction of ROS associated with the progression of oxidative stress [39, 40]. Furthermore, CPF has also been shown to activate apoptosis through upregulation of proapoptotic proteins in liver tissue [41]. Antioxidant treatment has been strongly linked with inhibition of chemical-induced apoptosis [19]. RBR coadministration with CPF exerted antiapoptotic activity through upregulation of Bcl-2 and downregulation of Bax and caspase-3. In addition, [25] showed that treatment with red beetroot increased the expression of Bcl-2 and decreased the expression of Bax and caspase-3 in gentamicin-treated rats.

5. Conclusion

We showed that CPF administration increased markers of kidney dysfunction, caused an imbalance between oxidative stress markers (MDA and NO) and antioxidant effectors (GSH, SOD, CAT, GPx, GR, and Nrf2), increased proinflammatory cytokine production, and induced apoptosis in renal tissue. However, RBR treatment prior to CPF administration reversed these changes in renal tissue through antioxidant, anti-inflammatory, and antiapoptotic mechanisms.

Data Availability

The data used to support the findings of this study are included within the article.

Conflicts of Interest

The authors declare no conflicts of interest.


The authors would like to extend their sincere appreciation to the Research Supporting Project number: RSP-2019/95, King Saud University, Riyadh, Saudi Arabia, for supporting the study.


  1. S. M. Mahmoud, A. E. Abdel Moneim, M. M. Qayed, and N. A. El-Yamany, “Potential role of N-acetylcysteine on chlorpyrifos-induced neurotoxicity in rats,” Environmental Science and Pollution Research, vol. 26, no. 20, pp. 20731–20741, 2019. View at: Publisher Site | Google Scholar
  2. L. Perić and P. Burić, “The effect of copper and chlorpyrifos co-exposure on biomarkers in the marine mussel Mytilus galloprovincialis,” Chemosphere, vol. 225, pp. 126–134, 2019. View at: Publisher Site | Google Scholar
  3. M. W. Zhao, P. Yang, and L. L. Zhao, “Chlorpyrifos activates cell pyroptosis and increases susceptibility on oxidative stress-induced toxicity by miR-181/SIRT1/PGC-1α/Nrf2 signaling pathway in human neuroblastoma SH-SY5Y cells: implication for association between chlorpyrifos and Parkinson’s disease,” Environmental Toxicology, vol. 34, no. 6, pp. 699–707, 2019. View at: Publisher Site | Google Scholar
  4. M. M. Romeiras, A. Vieira, D. N. Silva et al., “Evolutionary and biogeographic Insights on the macaronesian Beta-patellifolia species (Amaranthaceae) from a time-scaled molecular phylogeny,” PLoS One, vol. 11, no. 3, Article ID e0152456, 2016. View at: Publisher Site | Google Scholar
  5. N. Chhikara, K. Kushwaha, P. Sharma, Y. Gat, and A. Panghal, “Bioactive compounds of beetroot and utilization in food processing industry: a critical review,” Food Chemistry, vol. 272, pp. 192–200, 2019. View at: Publisher Site | Google Scholar
  6. G. J. Kapadia and G. S. Rao, “Anticancer effects of red beet pigments,” in Red Beet Biotechnology: Food and Pharmaceutical Applications, B. Neelwarne, Ed., pp. 125–154, Springer, Boston, MA, USA, 2012. View at: Google Scholar
  7. K. E. Lansley, P. G. Winyard, J. Fulford et al., “Dietary nitrate supplementation reduces the O2 cost of walking and running: a placebo-controlled study,” Journal of Applied Physiology, vol. 110, no. 3, pp. 591–600, 2011. View at: Publisher Site | Google Scholar
  8. D. C. Peiris and T. Dhanushka, “Low doses of chlorpyrifos interfere with spermatogenesis of rats through reduction of sex hormones,” Environmental Science and Pollution Research, vol. 24, no. 26, pp. 20859–20867, 2017. View at: Publisher Site | Google Scholar
  9. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at: Google Scholar
  10. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at: Publisher Site | Google Scholar
  11. L. C. Green, D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum, “Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids,” Analytical Biochemistry, vol. 126, no. 1, pp. 131–138, 1982. View at: Publisher Site | Google Scholar
  12. Y. Sun, L. W. Oberley, and Y. Li, “A simple method for clinical assay of superoxide dismutase,” Clinical Chemistry, vol. 34, no. 3, pp. 497–500, 1988. View at: Google Scholar
  13. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984. View at: Publisher Site | Google Scholar
  14. D. E. Paglia and W. N. Valentine, “Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase,” The Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158–169, 1967. View at: Google Scholar
  15. V. M. Factor, A. Kiss, J. T. Woitach, P. J. Wirth, and S. S. Thorgeirsson, “Disruption of redox homeostasis in the transforming growth factor-α/c-myc transgenic mouse model of accelerated hepatocarcinogenesis,” The Journal of Biological Chemistry, vol. 273, no. 25, pp. 15846–15853, 1998. View at: Publisher Site | Google Scholar
  16. G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochemistry and Biophysics, vol. 82, no. 1, pp. 70–77, 1959. View at: Publisher Site | Google Scholar
  17. A. E. Abdel Moneim, “Indigofera oblongifolia prevents lead acetate-induced hepatotoxicity, oxidative stress, fibrosis and apoptosis in rats,” PLoS One, vol. 11, no. 7, Article ID e0158965, 2016. View at: Publisher Site | Google Scholar
  18. M. W. Pfaffl, “A new mathematical model for relative quantification in real-time RT-PCR,” Nucleic Acids Research, vol. 29, no. 9, p. e45, 2001. View at: Publisher Site | Google Scholar
  19. A. Y. Al-Brakati, M. S. Fouda, A. M. Tharwat, E. K. Elmahallawy, R. B. Kassab, and A. E. Abdel Moneim, “The protective efficacy of soursop fruit extract against hepatic injury associated with acetaminophen exposure is mediated through antioxidant, anti-inflammatory, and anti-apoptotic activities,” Environmental Science and Pollution Research, vol. 26, no. 13, pp. 13539–13550, 2019. View at: Publisher Site | Google Scholar
  20. N. Salyha and Y. Salyha, “Protective role of l-glutamic acid and l-cysteine in mitigation the chlorpyrifos-induced oxidative stress in rats,” Environmental Toxicology and Pharmacology, vol. 64, pp. 155–163, 2018. View at: Publisher Site | Google Scholar
  21. M. Saoudi, I. B. Hmida, W. Kammoun, F. B. Rebah, K. Jamoussi, and A. E. Feki, “Protective effects of oil of Sardinella pilchardis against subacute chlorpyrifos-induced oxidative stress in female rats,” Archives of Environmental & Occupational Health, vol. 73, no. 2, pp. 128–135, 2018. View at: Publisher Site | Google Scholar
  22. N. Baba, R. Raina, P. Verma, and M. Sultana, “Free radical-induced nephrotoxicity following repeated oral exposureto chlorpyrifos alone and in conjunction with fluoride in rats,” Turkish Journal of Medical Sciences, vol. 46, pp. 512–517, 2016. View at: Publisher Site | Google Scholar
  23. S. E. Owumi and U. J. Dim, “Manganese suppresses oxidative stress, inflammation and caspase-3 activation in rats exposed to chlorpyrifos,” Toxicology Reports, vol. 6, pp. 202–209, 2019. View at: Publisher Site | Google Scholar
  24. M. Oncu, F. Gultekin, E. Karaöz, I. Altuntas, and N. Delibas, “Nephrotoxicity in rats induced by chlorpryfos-ethyl and ameliorating effects of antioxidants,” Human & Experimental Toxicology, vol. 21, no. 4, pp. 223–230, 2002. View at: Publisher Site | Google Scholar
  25. A. A. El Gamal, M. S. AlSaid, M. Raish et al., “Beetroot (Beta vulgaris L.) extract ameliorates gentamicin-induced nephrotoxicity associated oxidative stress, inflammation, and apoptosis in rodent model,” Mediators of Inflammation, vol. 2014, Article ID 983952, 12 pages, 2014. View at: Publisher Site | Google Scholar
  26. A. Al-Brakati, R. Kassab, M. Lokman, E. Elmahallawy, H. Amin, and A. Abdel Moneim, “Role of thymoquinone and ebselen in the prevention of sodium arsenite-induced nephrotoxicity in female rats,” Human & Experimental Toxicology, vol. 38, no. 4, pp. 482–493, 2019. View at: Publisher Site | Google Scholar
  27. T. Homma and J. Fujii, “Application of glutathione as anti-oxidative and anti-aging drugs,” Current Drug Metabolism, vol. 16, no. 7, pp. 560–571, 2015. View at: Publisher Site | Google Scholar
  28. N. M. El-Sayed, A. A. M. Ahmed, and M. A. A. Selim, “Cytotoxic effect of chlorpyrifos is associated with activation of Nrf-2/HO-1 system and inflammatory response in tongue of male Wistar rats,” Environmental Science and Pollution Research, vol. 25, no. 12, pp. 12072–12082, 2018. View at: Publisher Site | Google Scholar
  29. S. Li, H.-Y. Tan, N. Wang et al., “The role of oxidative stress and antioxidants in liver diseases,” International Journal of Molecular Sciences, vol. 16, no. 11, pp. 26087–26124, 2015. View at: Publisher Site | Google Scholar
  30. R. B. Kassab, M. S. Lokman, and E. A. Essawy, “Neurochemical alterations following the exposure to di-n-butyl phthalate in rats,” Metabolic Brain Disease, vol. 34, no. 1, pp. 235–244, 2018. View at: Publisher Site | Google Scholar
  31. Q. Ma, “Role of Nrf2 in oxidative stress and toxicity,” Annual Review of Pharmacology and Toxicology, vol. 53, no. 1, pp. 401–426, 2013. View at: Publisher Site | Google Scholar
  32. T. Clifford, G. Howatson, D. West, and E. Stevenson, “The potential benefits of red beetroot supplementation in health and disease,” Nutrients, vol. 7, no. 4, pp. 2801–2822, 2015. View at: Publisher Site | Google Scholar
  33. J. J. Vulić, T. N. Ćebović, J. M. Čanadanović-Brunet et al., “In vivo and in vitro antioxidant effects of beetroot pomace extracts,” Journal of Functional Foods, vol. 6, pp. 168–175, 2014. View at: Publisher Site | Google Scholar
  34. C. Carrillo, R. Rey, M. Hendrickx, M. del Mar Cavia, and S. Alonso-Torre, “Antioxidant capacity of beetroot: traditional vs novel approaches,” Plant Foods for Human Nutrition, vol. 72, no. 3, pp. 266–273, 2017. View at: Publisher Site | Google Scholar
  35. D. Vieira Teixeira da Silva, D. Dos Santos Baiao, F. de Oliveira Silva et al., “Betanin, a natural food additive: stability, bioavailability, antioxidant and preservative ability assessments,” Molecules, vol. 24, no. 3, p. 458, 2019. View at: Publisher Site | Google Scholar
  36. J. O. Lundberg, M. Carlström, F. J. Larsen, and E. Weitzberg, “Roles of dietary inorganic nitrate in cardiovascular health and disease,” Cardiovascular Research, vol. 89, no. 3, pp. 525–532, 2011. View at: Publisher Site | Google Scholar
  37. P. J. Vidal, J. M. López-Nicolás, F. Gandía-Herrero, and F. García-Carmona, “Inactivation of lipoxygenase and cyclooxygenase by natural betalains and semi-synthetic analogues,” Food Chemistry, vol. 154, pp. 246–254, 2014. View at: Publisher Site | Google Scholar
  38. Y. Zhang, Y. Chang, H. Cao, W. Xu, Z. Li, and L. Tao, “Potential threat of Chlorpyrifos to human liver cells via the caspase-dependent mitochondrial pathways,” Food and Agricultural Immunology, vol. 29, no. 1, pp. 294–305, 2018. View at: Publisher Site | Google Scholar
  39. F. Yu, Z. Wang, B. Ju, Y. Wang, J. Wang, and D. Bai, “Apoptotic effect of organophosphorus insecticide chlorpyrifos on mouse retina in vivo via oxidative stress and protection of combination of vitamins C and E,” Experimental and Toxicologic Pathology, vol. 59, no. 6, pp. 415–423, 2008. View at: Publisher Site | Google Scholar
  40. J. E. Lee, J. H. Park, I. C. Shin, and H. C. Koh, “Reactive oxygen species regulated mitochondria-mediated apoptosis in PC12 cells exposed to chlorpyrifos,” Toxicology and Applied Pharmacology, vol. 263, no. 2, pp. 148–162, 2012. View at: Publisher Site | Google Scholar
  41. W. R. Mohamed, A. B. M. Mehany, and R. M. Hussein, “Alpha lipoic acid protects against chlorpyrifos-induced toxicity in Wistar rats via modulating the apoptotic pathway,” Environmental Toxicology and Pharmacology, vol. 59, pp. 17–23, 2018. View at: Publisher Site | Google Scholar

Copyright © 2019 Gadah Albasher et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

565 Views | 321 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.